to AMGEN!!!! Certainly!
Helen is a strategic thinker with broad operating and general management experience," said Dr. Coles. "Her track record of successfully growing established brands such as Epogen® and Aranesp® in nephrology and of leading multiple successful product launches − including Prolia®, Sensipar®, and Miacalcin®− will be instrumental as we prepare for the potential launch of carfilzomib, our next-generation proteasome inhibitor, and the next stage of Nexavar's growth. We will also rely on Helen's significant expertise to expand our commercial organization internationally."
Unfortunately nobody is invincible...... I better stick to AVNR, more visibility now!
.... and do not listen to these guys about vaseline and all, keep faith and will definetly be awarded.
I wonder why but bought some calls just in case.........
especially judging by the numbers of foolish bashing posts.
Well, who can blame!? "Play the game" as Mercury sang long ago ..... Probably those shorts or bashers even do not know who Mercury is!